Floatz logo

Activated T Cells

Impetigo

Centro Studi GisedCell therapyN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Impetigo cohort.

Asset / SponsorPhaseRating
Prevnar
Centro Studi Gised
N/AD
gi-4000
Centro Studi Gised
N/AD

Same molecule, other indications

Activated T Cells is also rated in:

relapsing-remitting multiple sclerosisDormant
CC
Indicative ·
45 / 100
View asset →
glioblastomaDormant
CC
Indicative ·
41 / 100
View asset →
Chronic Lymphocytic LeukemiaDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →